Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Yes, adults do get RSV, and infection can range from mild cold-like symptoms to serious lower respiratory illness such as bronchiolitis or pneumonia. Risk of severe disease is highest in adults age 60 and older, those with chronic heart or lung conditions like COPD, asthma, or heart failure, people with weakened immune systems, adults with diabetes or obesity, and residents of nursing homes or long-term care facilities. Reinfection is common throughout life because immunity after RSV is short-lived, so a previous case does not protect you. There are several important details to consider, including warning signs that call for urgent care and who may benefit from RSV vaccination, so review the complete answer below.
If you are coughing, wheezing, or feeling short of breath and unsure whether it is RSV, flu, COVID-19, or something else, guessing can delay treatment that works best in the first few days of illness. A free, instant, online symptom check lets you describe what you are experiencing in a few minutes and receive possible causes along with clear guidance on whether to rest at home, book a visit, or seek urgent care, so you can act with confidence instead of uncertainty.
Last reviewed for medical accuracy: 09/23/2026
Respiratory syncytial virus (RSV) is often thought of as a childhood illness, but adults can—and do—get RSV. Understanding who’s most at risk, how it presents, and what you can do to protect yourself helps keep you and those around you safer and healthier.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms. It spreads easily through droplets when an infected person coughs or sneezes, or by touching surfaces contaminated with the virus.
Key points:
Yes. While RSV is best known for causing severe infections in infants and young children, adults of all ages can contract it. In most healthy adults, RSV causes symptoms similar to a mild cold:
Symptoms usually appear 4–6 days after exposure and resolve within one to two weeks.
Although most healthy adults experience only mild illness, certain groups face higher risks of complications—including pneumonia and bronchitis—that may require hospitalization.
High-risk groups include:
Seek medical attention if you experience:
For non-urgent concerns, you might start with a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Diagnosis often relies on clinical evaluation. In mild cases, testing may not be necessary. However, if your symptoms are severe or you belong to a high-risk group, your healthcare provider may order:
There’s no specific antiviral treatment approved for RSV in most healthy adults. Management focuses on relieving symptoms and preventing complications.
Self-care measures:
For high-risk adults or severe cases:
Although you can’t eliminate risk entirely, these steps help reduce your chances of getting RSV or passing it on:
Practice good hand hygiene
Avoid close contact with sick individuals
Clean and disinfect surfaces
Cover coughs and sneezes
Stay home when ill
Consider vaccination (where available)
RSV, influenza, and COVID-19 can all cause respiratory symptoms. Here’s a quick comparison:
| Feature | RSV | Flu | COVID-19 |
|---|---|---|---|
| Onset | Gradual (4–6 days) | Sudden (1–4 days) | Gradual to sudden (2–14 days) |
| Fever | Low or none | Common, often high | Common, variable |
| Aches & chills | Mild | Prominent | Prominent |
| Cough | Common | Common | Common |
| Severe complications | Mostly in high-risk | High in high-risk | High in high-risk |
Accurate diagnosis may require testing since symptoms overlap. If you’re unsure which illness you have, try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Contact your healthcare provider if you:
Never ignore symptoms that feel serious or life threatening. If you’re in crisis (severe breathing difficulty, chest pain, sudden confusion), call emergency services immediately.
Staying informed and taking simple precautions goes a long way in protecting yourself and your community from RSV and other respiratory viruses. If you’re ever in doubt about your symptoms, always reach out to a healthcare professional.
(References)
* Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009 Feb 5;360(6):588-98. doi: 10.1056/NEJMoa0804877. PMID: 19196675; PMCID: PMC4829966.
* Buchwald AG, Tamboura B, Tennant SM, Haidara FC, Coulibaly F, Doumbia M, Diallo F, Keita AM, Sow SO, Kotloff KL, Levine MM, Tapia MD. Epidemiology, Risk Factors, and Outcomes of Respiratory Syncytial Virus Infections in Newborns in Bamako, Mali. Clin Infect Dis. 2020 Jan 1;70(1):59-66. doi: 10.1093/cid/ciz157. PMID: 30810160; PMCID: PMC6912158.
* Khan L. Respiratory Syncytial Virus. Pediatr Ann. 2022 Oct;51(10):e376-e378. doi: 10.3928/19382359-20220807-01. Epub 2022 Oct 1. PMID: 36215084.
* Wang X, Li Y, Shi T, Bont LJ, Chu HY, Zar HJ, Wahi-Singh B, Ma Y, Cong B, Sharland E, Riley RD, Deng J, Figueras-Aloy J, Heikkinen T, Jones MH, Liese JG, Markić J, Mejias A, Nunes MC, Resch B, Satav A, Yeo KT, Simões EAF, Nair H, Respiratory Virus Global Epidemiology Network, RESCEU investigators. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. Lancet. 2024 Mar 30;403(10433):1241-1253. doi: 10.1016/S0140-6736(24)00138-7. Epub 2024 Feb 14. PMID: 38367641.
* Deng S, Cong B, Edgoose M, De Wit F, Nair H, Li Y. Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis. Int J Infect Dis. 2024 Sep;146:107125. doi: 10.1016/j.ijid.2024.107125. Epub 2024 Jun 28. PMID: 38945430.
* Kirolos N, Mtaweh H, Datta RR, Farrar DS, Seaton C, Bone JN, Muttalib F, Kaziev CL, Fortini J, Mahant S, Campigotto A, Freire G, Yeung RSM, Rayment JH, Yang C, Srigley JA, Sadarangani M, Buchanan F, Morris SK, Gill PJ, READAPT-Kids Study Group Members. Risk Factors for Severe Disease Among Children Hospitalized With Respiratory Syncytial Virus. JAMA Netw Open. 2025 Apr 1;8(4):e254666. doi: 10.1001/jamanetworkopen.2025.4666. Epub 2025 Apr 1. PMID: 40214990; PMCID: PMC11992603.
* Ma R, Zhang C, Zhang Y, Tan H, Zhang Y, Li Q, Bai Y, Sun X. The impact of respiratory syncytial virus on asthma development and exacerbation. Ann Allergy Asthma Immunol. 2025 Sep;135(3):268-275. doi: 10.1016/j.anai.2025.05.011. Epub 2025 May 17. PMID: 40389152.
* Goldstein LA, Michaels MG, Salthouse A, Toepfer AP, Musa S, Hickey RW, Johnson M, Wang-Erickson AF, Weinberg GA, Szilagyi PG, Schlaudecker EP, Staat MA, Sahni LC, Boom JA, Klein EJ, Englund JA, Schuster JE, Selvarangan R, Harrison CJ, Halasa NB, Stewart LS, Dawood FS, Moline HL, Williams JV. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 1;156(3). doi: 10.1542/peds.2024-070218. PMID: 40763933; PMCID: PMC12824835.
* Buttarelli L, Caselli E, Gerevini S, Leuratti P, Gambadauro A, Manti S, Esposito S. Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection. Viruses. 2025 Jul 31;17(8). doi: 10.3390/v17081073. Epub 2025 Jul 31. PMID: 40872787; PMCID: PMC12390669.
* Frivold C, Cox SN, Starita L, Babu TM, Hoffman KL, Carone M, Lockwood CM, Kuntz JL, Mularski RA, Varga A, Han PD, Reed J, Piliper EA, Mohamed Bakhash SAK, Greninger AL, Clark E, Stone J, Grindstaff S, Boisvert CL, Yetz N, Lo NK, Hatchie TL, Marshall G, Wolock CJ, Feldstein LR, Weil AA, Englund JA, Naleway AL, Chu HY. Correlates of risk of respiratory syncytial virus disease: a prospective cohort study. Nat Commun. 2025 Sep 26;16(1):8490. doi: 10.1038/s41467-025-63434-x. Epub 2025 Sep 26. PMID: 41006233; PMCID: PMC12475016.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.